Generics Leading Indian drugmaker Ranbaxy Laboratories (RANB: BO), which is 64% owned by Japan's Daiichi Sankyo (TKO: 4568), has reported consolidated sales of $406 million, a rise of 13% over the like 2009 period. Earnings before interest, tax, depreciation and amortization (EBITDA) were at $29 million, a margin of 7% to sales, but well down on the $44 million reported last year. 12 November 2010